Swayamprakash Patel Selected Research

N(6)- (4- amino- 3- iodobenzyl)adenosine- 5'- N- methyluronamide

1/2022

Pharmacological Study of A3 Adenosine Receptor agonist (AB Meca) in Xenograft Lung Cancer Model in Mice through In Silico and In Vivo Approach: Targeting TNF-α.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Swayamprakash Patel Research Topics

Disease

1	Alcoholism (Alcohol Abuse) 04/2022
1	Arthritis (Polyarthritis) 04/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Neoplasms (Cancer) 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022

Drug/Important Bio-Agent (IBA)

1	Hypoglycemic Agents (Hypoglycemics)IBA 04/2022
1	CosmeticsIBA 04/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2022
1	N(6)- (4- amino- 3- iodobenzyl)adenosine- 5'- N- methyluronamideIBA 01/2022
1	Aromatase InhibitorsIBA 01/2022
1	Aromatase (CYP19)IBA 01/2022
1	Estrogens (Estrogen)FDA Link 01/2022
1	FlavonoidsIBA 01/2022
1	LigandsIBA 01/2022

Therapy/Procedure

1	Condoms (Condom) 04/2022
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 04/2022
1	Therapeutics 01/2022